Join to View Full Profile
240 W. Thomas RoadSuite 301Phoenix, AZ 85013
Phone+1 602-406-3138
Dr. Racette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Brad Racette is a neurologist based in Phoenix, AZ, specializing in movement disorders. He completed his medical education at Northwestern University The Feinberg School of Medicine, followed by an internal medicine internship and a neurology residency. He currently serves as the Kemper and Ethel Marley Professor and Chairman of Neurology and Senior Vice President at Barrow Neurological Institute. His career includes extensive experience treating general neurology and movement disorders, notably Parkinson's disease and using botulinum toxin injections. Dr. Racette has contributed to numerous publications and was involved in clinical trials, such as the CREST-E study. He has received several honors, including the Regional Top Doctor recognition from Castle Connolly.
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 1993 - 1996
McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 1992 - 1993- Northwestern University The Feinberg School of MedicineClass of 1992
Princeton UniversityAB, Molecular Biology, Cum Laude, 1984 - 1988
Certifications & Licensure
AZ State Medical License 2022 - 2026
MO State Medical License 1996 - 2023
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013-2017
- CMS Meaningful Use Stage Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013-2017
- CMS Meaningful Use Stage Stage 1 Certification RxNT EHR, Networking Technology dba RxNT, 2013-2017
Clinical Trials
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- Excess risk of fracture in incident Parkinson's disease Medicare beneficiaries.Alejandra Camacho-Soto, Irene M Faust, Brittany Krzyzanowski, Jordan A Killion, Kassu M Beyene
Injury Epidemiology. 2026-01-12 - Cholinergic dysfunction in occupational manganese exposure.T Noah Hutson, Susan Searles Nielsen, Natalie Senini, John O'Donnell, Hubert P Flores
Neurotoxicology. 2025-12-01 - 1 citationsAmbient Trichloroethylene Exposure and Parkinson Disease Risk in Medicare Beneficiaries.Brittany Krzyzanowski, Kassu Mehari Beyene, Jay R Turner, Brad A Racette
Neurology. 2025-10-21
Press Mentions
Cardiometabolic Risk Factors Account for More Than One-Third of Dementia RiskJune 6th, 2025- Study Finds Geographic Link Between Dementia and Cardiometabolic DiseaseJune 3rd, 2025
- Dementia Tied to Heart, Metabolic DiseasesMay 29th, 2025
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
